Business Collaborative for Brain Health Partners with HERO to Launch the Brain Health Best Practice Score for Employers
19. September 2024 13:30 ET
|
UsAgainstAlzheimer's
New educational tool will help companies assess how well their health and well-being programs support their workforce’s brain health, a critical factor in employees’ overall health, performance and...
UsAgainstAlzheimer’s Launches 2024 Brain Health Academy
16. April 2024 10:48 ET
|
UsAgainstAlzheimer's
WASHINGTON, April 16, 2024 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s today announced the return of its Brain Health Academy, scheduled to begin on May 9, 2024. First launched in 2022, the Academy...
Congress Passes Bills Making Major Investments in Alzheimer’s
23. März 2024 10:15 ET
|
UsAgainstAlzheimer's
Congress passes major investments in the fight against Alzheimer’s.
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’s
08. März 2024 07:55 ET
|
UsAgainstAlzheimer's
WASHINGTON, March 08, 2024 (GLOBE NEWSWIRE) -- The maker of donanemab, Eli Lilly, announced today that the Food and Drug Administration (FDA) will convene an advisory committee to consider the...
Organizations Unite to Improve Brain Health
08. Februar 2024 11:52 ET
|
UsAgainstAlzheimer's
Washington, DC, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Today, UsAgainstAlzheimer’s, along with collaborators AARP, GN Group, Eli Lilly, and Novo Nordisk, launched the Business Collaborative for Brain...
Alzheimer’s Leaders Discuss How to Shift Science into Clinical Practice During National Alzheimer’s Summit
20. Oktober 2023 12:58 ET
|
UsAgainstAlzheimer's
Washington, DC, Oct. 20, 2023 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s this week hosted the 2023 National Alzheimer’s Summit, a groundbreaking event dedicated to applying recent scientific and...
UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi for Treatment of Early-Stage Alzheimer’s
06. Juli 2023 17:35 ET
|
UsAgainstAlzheimer's
Washington, DC, July 06, 2023 (GLOBE NEWSWIRE) -- Patient advocacy organization UsAgainstAlzheimer’s today hailed the first-of-its-kind traditional approval by the Food and Drug Administration (FDA)...
Brain Health Academy Enrollment is Now Open, First Session Launches May 17
24. April 2023 11:05 ET
|
UsAgainstAlzheimer's
Washington, DC, April 24, 2023 (GLOBE NEWSWIRE) -- Following the launch of its highly successful Brain Health Academy in 2022, UsAgainstAlzheimer’s today announced class will be back in session...
Sen. Collins, Rep. Eshoo Decry Medicare Coverage Rejection of Alzheimer’s Drugs
18. Oktober 2022 15:12 ET
|
UsAgainstAlzheimer's
Washington, D.C., Oct. 18, 2022 (GLOBE NEWSWIRE) -- During UsAgainstAlzheimer’s 2022 National Summit, members of Congress, scientists, and other leaders spoke out against the Centers for Medicare...
TODAY: CMS Controversy, Rep. Eshoo, Nationally Recognized Scientists to Take Center Stage at UsAgainstAlzheimer’s National Summit
12. Oktober 2022 12:27 ET
|
UsAgainstAlzheimer's
Washington, DC, Oct. 12, 2022 (GLOBE NEWSWIRE) -- With the federal government’s decision to deny Medicare coverage of an entire class of Alzheimer’s treatments, as well as the promising clinical...